| 1 |
32251643 | Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory Features. | 2020 Jul |
1 |
| 2 |
29307841 | ROS-Mediated 15-Hydroxyprostaglandin Dehydrogenase Degradation via Cysteine Oxidation Promotes NAD+-Mediated Epithelial-Mesenchymal Transition. | 2018 Mar 15 |
5 |
| 3 |
29039590 | MicroRNA‑218 promotes prostaglandin E2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15‑hydroxyprostaglandin dehydrogenase [NAD(+)]. | 2017 Dec |
2 |
| 4 |
27404282 | NADH:Cytochrome b5 Reductase and Cytochrome b5 Can Act as Sole Electron Donors to Human Cytochrome P450 1A1-Mediated Oxidation and DNA Adduct Formation by Benzo[a]pyrene. | 2016 Aug 15 |
2 |
| 5 |
26068950 | miR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD). | 2015 Sep 8 |
1 |
| 6 |
26466337 | Molecular Characterization and Functional Analysis of Cytochrome b5 Reductase (CBR) Encoding Genes from the Carotenogenic Yeast Xanthophyllomyces dendrorhous. | 2015 |
3 |
| 7 |
24699315 | miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth. | 2014 Jun |
1 |
| 8 |
24760190 | Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD). | 2014 Apr 23 |
1 |
| 9 |
23442768 | Regional differences in prostaglandin E₂ metabolism in human colorectal cancer liver metastases. | 2013 Feb 26 |
5 |
| 10 |
22499122 | Identification of distinct gene expression profiles between esophageal squamous cell carcinoma and adjacent normal epithelial tissues. | 2012 Apr |
1 |
| 11 |
20699658 | 15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human gastric cancer. | 2010 Oct 15 |
1 |
| 12 |
21735612 | Potent and selective inhibitors of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (HPGD) | 2010 |
3 |
| 13 |
19887544 | Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression. | 2009 Nov |
3 |
| 14 |
18174234 | Expression of 15-PGDH is downregulated by COX-2 in gastric cancer. | 2008 Jun |
1 |
| 15 |
18646549 | Cytochrome P450 polymorphism--molecular, metabolic and pharmacogenetic aspects. I. Mechanisms of activity of cytochrome P450 monooxygenases. | 2008 May-Jun |
2 |
| 16 |
17481556 | 15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer. | 2007 May |
2 |
| 17 |
16757471 | Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. | 2006 Aug 11 |
1 |
| 18 |
16828555 | Role of glutamine 148 of human 15-hydroxyprostaglandin dehydrogenase in catalytic oxidation of prostaglandin E2. | 2006 Oct 1 |
1 |
| 19 |
15581601 | Key NAD+-binding residues in human 15-hydroxyprostaglandin dehydrogenase. | 2005 Jan 15 |
3 |
| 20 |
15908215 | Understanding human 15-hydroxyprostaglandin dehydrogenase binding with NAD+ and PGE2 by homology modeling, docking and molecular dynamics simulation. | 2005 Jul 15 |
3 |
| 21 |
14749354 | Synergistic induction of the nicotinamide adenine dinucleotide-linked 15-hydroxyprostaglandin dehydrogenase by an androgen and interleukin-6 or forskolin in human prostate cancer cells. | 2004 May |
3 |
| 22 |
12605868 | Continuous spectrophotometric assay amenable to 96-well plate format for prostaglandin E synthase activity. | 2003 Feb 15 |
1 |
| 23 |
12468268 | Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents. | 2002 Dec |
2 |
| 24 |
11006085 | Induction of NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells. | 2000 Sep 16 |
1 |
| 25 |
8344929 | Photoaffinity labeling of human placental NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase with [alpha-32P]2N3NAD+. Identification of a peptide in the adenine ring binding domain. | 1993 Aug 5 |
3 |
| 26 |
1612526 | Localization of 15-hydroxy prostaglandin dehydrogenase in human fetal membranes, decidua, and placenta during pregnancy. | 1992 |
1 |
| 27 |
2059213 | Regulation of synthesis and activity of NAD(+)-dependent 15-hydroxy-prostaglandin dehydrogenase (15-PGDH) by dexamethasone and phorbol ester in human erythroleukemia (HEL) cells. | 1991 Jun 28 |
2 |
| 28 |
2240085 | Immunocytochemical distribution and localization of 15-hydroxyprostaglandin dehydrogenase in human fetal membranes, decidua, and placenta. | 1990 Nov |
1 |
| 29 |
2337593 | Purification and structural characterization of placental NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase. The primary structure reveals the enzyme to belong to the short-chain alcohol dehydrogenase family. | 1990 Jan 23 |
2 |
| 30 |
3348868 | New inhibitor(s) of 15-hydroxyprostaglandin dehydrogenase in human milk. | 1988 Apr |
1 |
| 31 |
4074386 | Inactivation of pulmonary NAD+-dependent 15-hydroxyprostaglandin dehydrogenase by acrolein. | 1985 Dec 15 |
2 |
| 32 |
7248931 | Nicotinamide adenine dinucleotide-dependent 15-hydroxyprostaglandin dehydrogenase activity in hydatidiform mole tissue and choriocarcinoma cells. | 1981 Jul |
3 |
| 33 |
6252782 | Early steps in prostaglandin metabolism in the human placenta. | 1980 Nov 1 |
2 |
| 34 |
171213 | [15-Hydroxyprostaglandin dehydrogenase from human placenta, II. Steady state kinetics and influence of prostaglandin F2alpha analogues (author's transl)]. | 1975 Jun |
1 |